$31.33
-0.25 (-0.79%)
Performance
1D
—
1W
—
1M
—
3M
+6.93%
6M
-17.05%
1Y
+13.72%
YTD
-11.55%
Open$31.63
Previous Close$31.58
Day High$31.90
Day Low$31.14
52W High$43.15
52W Low$22.96
Volume—
Avg Volume2.69M
Market Cap3.64B
P/E Ratio—
EPS$-3.18
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.83
Below
SMA 200
$31.34
Below
RSI (14)
52.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+117.7% upside
Current
$31.33
$31.33
Target
$68.21
$68.21
$46.84
$68.21 avg
$80.11
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.82B | 1.78B | 1.68B |
| Net Income | 202.06M | 220.26M | 147.13M |
| Profit Margin | 11.1% | 12.3% | 8.7% |
| EBITDA | 246.26M | 251.94M | 230.42M |
| Free Cash Flow | 210.43M | 219.41M | 153.78M |
| Rev Growth | +17.6% | -0.7% | +11.4% |
| Debt/Equity | 0.22 | 0.23 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |